Myocarditis echocardiography

Jump to navigation Jump to search

Myocarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Adrenergic Myocarditis
Giant Cell Myocarditis

Causes

Differentiating Myocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myocarditis echocardiography On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Myocarditis echocardiography

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myocarditis echocardiography

CDC on Myocarditis echocardiography

Myocarditis echocardiography in the news

Blogs on Myocarditis echocardiography

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Myocarditis echocardiography

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S.

Overview

Echocardiography in patients with myocarditis allows for serial assessment of left ventricular dysfunction. Echocardiography is helpful in differentiating acute from fulminant myocarditis[1].

Echocardiography

Echocardiographic findings in myocardits include:

  • Wall motion abnormalities[2].
  • Systolic dysfunction[2][3].
  • Diastolic dysfunction[4].
  • Changes in image texture on echocardiogram, i.e. increase in brightness, heterogeneity, and contrast[5].
  • Fulminant myocarditis appear as nondilated, thickened and hypocontractile left ventricle with increased septal thickness. While, those with acute myocarditis have a marked left ventricular dilation, normal septal thickness and decreased ventricular function[1].
  • Pericardial effusion may be noted in few patients.
  • Functional regurgitation through the AV valves may be noted in patients with dilated ventricles.
  • Cardiac function may be monitored over a period. And it is found to improve in fulminant myocarditis over approximately 6 months[1].

References

  1. 1.0 1.1 1.2 Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL; et al. (2000). ; "Echocardiographic findings in fulminant and acute myocarditis" Check |url= value (help). J Am Coll Cardiol. 36 (1): 227–32. PMID 10898439.
  2. 2.0 2.1 Pinamonti B, Alberti E, Cigalotto A, Dreas L, Salvi A, Silvestri F; et al. (1988). "Echocardiographic findings in myocarditis". Am J Cardiol. 62 (4): 285–91. PMID 3400607.
  3. Nieminen MS, Heikkilä J, Karjalainen J (1984). "Echocardiography in acute infectious myocarditis: relation to clinical and electrocardiographic findings". Am J Cardiol. 53 (9): 1331–7. PMID 6711435.
  4. James KB, Lee K, Thomas JD, Hobbs RE, Rincon G, Bott-Silverman C; et al. (1994). "Left ventricular diastolic dysfunction in lymphocytic myocarditis as assessed by Doppler echocardiography". Am J Cardiol. 73 (4): 282–5. PMID 8296760.
  5. Lieback E, Hardouin I, Meyer R, Bellach J, Hetzer R (1996). "Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis". Eur Heart J. 17 (1): 135–42. PMID 8682119.

Template:WS Template:WH